Phosphatidylserine-exposing blood cells and microparticles induce procoagulant activity in non-valvular atrial fibrillation.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  International Journal of Cardiology

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2018.01.116PMID 29544920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Real world adherence to oral anticoagulant in non-valvular atrial fibrillation patients in China

  2018cited by this paper
• Cell-Derived Microparticles in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis

  2016cited by this paper
• Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood.

  2016cited by this paper
• Microparticles and blood cells induce procoagulant activity via phosphatidylserine exposure in NSTEMI patients following stent implantation.

  2016cited by this paper
• Exposure of phosphatidylserine on the cell surface

  2016cited by this paper
• Improved persistence with non-vitamin-K oral anticoagulants compared with warfarin in patients with atrial fibrillation: recent Australian experience

  2016cited by this paper
• Adherence to oral anticoagulant therapy in patients with atrial fibrillation

  2016cited by this paper
• Antiplatelet therapy: Vorapaxar in diabetes and MI

  2015cited by this paper
• Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation.

  2015cited by this paper
• Clinical Significance of Tissue Factor–Exposing Microparticles in Arterial and Venous Thrombosis

  2015cited by this paper
• Elevated levels of RDW is associated with non-valvular atrial fibrillation

  2014cited by this paper
• Fibrin clot properties and their modulation in thrombotic disorders

  2014cited by this paper
• A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity.

  2014cited by this paper
• Role of microparticles in endothelial dysfunction and arterial hypertension.

  2014cited by this paper
• Do Atrial Differences in Endothelial Damage, Leukocyte and Platelet Activation, or Tissue Factor Activity Contribute to Chamber‐Specific Thrombogenic Status in Patients with Atrial Fibrillation?

  2014cited by this paper
• Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells

  2013cited by this paper
• Encryption and decryption of tissue factor

  2013cited by this paper
• Microparticles in atrial fibrillation: a link between cell activation or apoptosis, tissue remodelling and thrombogenicity.

  2013cited by this paper
• Phosphatidylserine-mediated cellular signaling.

  2013cited by this paper
• Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome

  2012cited by this paper
• Inflammation in atrial fibrillation.

  2012cited by this paper
• Blood Clots Are Rapidly Assembled Hemodynamic Sensors: Flow Arrest Triggers Intraluminal Thrombus Contraction

  2012cited by this paper
• Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation.

  2012cited by this paper
• Cellular Mechanisms Underlying the Formation of Circulating Microparticles

  2011cited by this paper
• Lactadherin functions as a probe for phosphatidylserine exposure and as an anticoagulant in the study of stored platelets

  2011cited by this paper
• Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review

  2011cited by this paper
• Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation.

  2011cited by this paper
• Mechanics and contraction dynamics of single platelets and implications for clot stiffening.

  2011cited by this paper
• Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: involvement of mononuclear cell-platelet interaction.

  2011cited by this paper
• Increased serum levels of microvesicles in nonvalvular atrial fibrillation determinated by ELISA using a specific monoclonal antibody AD-1.

  2010cited by this paper
• Atrial platelet reactivity in patients with atrial fibrillation.

  2010cited by this paper
• Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.

  2009cited by this paper
• Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.

  2007cited by this paper
• Thrombolytic therapy for acute left atrial thrombus formation in one patient with heart failure and atrial fibrillation.

  2007cited by this paper
• Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation.

  2007cited by this paper
• Is atrial fibrillation an inflammatory disorder?

  2006cited by this paper
• Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5.

  2006cited by this paper
• Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites.

  2003cited by this paper
• Platelet P-Selectin Levels in Relation to Plasma Soluble P-Selectin and &bgr;-Thromboglobulin Levels in Atrial Fibrillation

  2002cited by this paper
• Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates.

  1998cited by this paper
• Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

  1998cited by this paper
• Stroke severity in atrial fibrillation. The Framingham Study.

  1996cited by this paper
• Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.

  1996cited by this paper
• Does atrial fibrillation confer a hypercoagulable state

  1995cited by this paper
• Does atrial fibrillation confer a hypercoagulable state?

  1995cited by this paper

• Procoagulant effect of phosphatidylserine-exposed blood cells, endothelial cells and extracellular vesicles in patients with aortic stenosis

  2025cites this paper
• Cardiovascular Toxicity of Metal-Based Nanoparticles

  2025cites this paper
• Platelet apoptosis markers under anticoagulation for COVID-19 infection

  2024cites this paper
• Evaluation of Inflammation and Platelet Apoptosis Parameters in Obese Patients in Various Types of Anticoagulant Prophylaxis of Venous Thromboembolic Complications in Context of COVID-19

  2024cites this paper
• Pro-coagulant effect of phosphodiesterase exposed to extracellular vesicles, blood cells and endothelial cells in patients with aortic stenosis

  2024cites this paper
• Red Blood Cells and Endothelium Derived Circulating Extracellular Vesicles in Health and Chronic Heart Failure: A Focus on Phosphatidylserine Dynamics in Vesiculation

  2023cites this paper
• Platelet Microvesicles, Inflammation, and Coagulation Markers: A Pilot Study

  2023cites this paper
• Annexin V- and tissue factor+ microparticles as biomarkers for predicting deep vein thrombosis in patients after joint arthroplasty.

  2022cites this paper
• The role of phosphatidylserine on the membrane in immunity and blood coagulation

  2022cites this paper
• Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation

  2022cites this paper
• Biomaterials-Enabled Antithrombotics: Recent Advances and Emerging Strategies

  2022cites this paper
• Pathophysiology of Coagulation and Emerging Roles for Extracellular Vesicles in Coagulation Cascades and Disorders

  2022cites this paper
• Neutrophil Extracellular Traps and Neutrophil-Derived Extracellular Vesicles: Common Players in Neutrophil Effector Functions

  2022cites this paper
• Extracellular Vesicles in Atrial Fibrillation—State of the Art

  2022cites this paper
• The Association of Glucose Control with Circulating Levels of Red Blood Cell-Derived Vesicles in Type 2 Diabetes Mellitus Patients with Atrial Fibrillation

  2022cites this paper
• Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence

  2021cites this paper
• Thrombocytopathies: Not Just Aggregation Defects—The Clinical Relevance of Procoagulant Platelets

  2021cites this paper
• Phosphatidylserine-exposing tumor-derived microparticles exacerbate coagulation and cancer cell transendothelial migration in triple-negative breast cancer

  2021cites this paper
• Biomarkers of Thrombo-Inflammatory Responses in Pulmonary Embolism Patients With Pre-Existing Versus New-Onset Atrial Fibrillation

  2021cites this paper
• Mechanisms of COVID-19 thrombosis in an inflammatory environment and new anticoagulant targets.

  2021cites this paper
• Nonvalvular atrial fibrillation patients anticoagulated with rivaroxaban compared with warfarin exhibit reduced circulating extracellular vesicles with attenuated pro‐inflammatory protein signatures

  2021cites this paper
• Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers

  2021cites this paper
• Neutrophil microvesicles and their role in disease.

  2021cites this paper
• The recent development of metal oxide heterostructures based gas sensor, their future opportunities and challenges: A review

  2021cites this paper
• Toxicokinetics of Arenobufagin and its Cardiotoxicity Mechanism Exploration Based on Lipidomics and Proteomics Approaches in Rats

  2021cites this paper
• Programmable release of 2-O-d-glucopyranosyl-l-ascorbic acid and heparin from PCL-based nanofiber scaffold for reduction of inflammation and thrombosis

  2020cites this paper
• Endothelial damage and a thin intercellular fibrin network promote haemorrhage in acute promyelocytic leukaemia

  2020cites this paper
• Impact of left atrial appendage closure on circulating microvesicles levels: The MICROPLUG study.

  2020cites this paper
• Extracellular vesicles in atrial fibrillation and stroke.

  2020cites this paper
• The microvesicle/CD36 complex triggers a prothrombotic phenotype in patients with non‐valvular atrial fibrillation

  2020cites this paper
• Altered profile of circulating microparticles in nonvalvular atrial fibrillation

  2019cites this paper
• Morphological determinators of platelet activation status in patients with atrial fibrillation.

  2019cites this paper
• Liquid Biopsies: Microvesicles in Cardiovascular Disease

  2019cites this paper
• Atrial fibrillation and cancer - An unexplored field in cardiovascular oncology.

  2019cites this paper
• Connecting atrial morphology with platelet reactivity: What the left atrial appendage can tell us about the procoagulant state in atrial fibrillation.

  2019cites this paper
• The role of neutrophils in thrombosis.

  2018cites this paper
• Induction of atrial endothelial senescence by angiotensin II and thrombin : role of oxidative stress and characterization of pro-thrombotic, pro-adhesive, proteolytic and pro-fibrotic phenotype

  2018cites this paper
• PS. It was me all along! Emergence of phosphatidylserine in the procoagulant state in atrial fibrillation.

  2018cites this paper